Table 2.
Demographics, presenting symptoms, and primary malignancy.
n (%) | |
---|---|
Age, years (mean) | 56 |
Gender | |
Men | 89 (56) |
Women | 71 (44) |
Risk factors for malignancy | |
Tobacco smoking | 9 (57) |
Alcohol use | 2 (50) |
Symptoms | |
Cough | 61 (85) |
Dyspnea | 102 (94) |
Hemoptysis | 9 (23) |
Fatigue | 11 (73) |
Weight loss | 10 (59) |
Abdominal pain | 11 (86) |
Night sweats | 5 (42) |
Syncope | 6 (43) |
Hypoxemia | 96 (95) |
Primary malignancy | |
Gastric | 94 (59) |
Breast | 16 (10) |
Lung | 10 (6) |
Urothelial | 6 (4) |
Unknown | 4 (3) |
Ovarian | 4 (3) |
Pancreatic | 3 (2) |
Esophageal | 3 (2) |
Prostate | 2 (1) |
Colon | 2 (1) |
Gallbladder | 2 (1) |
Hepatocellular, dual parotid gland/salivary duct, dual hepatocellular/cholangiocarcinoma, dual gastric/duodenal, cholangiocarcinoma, sphenoid sinus, gastroesophageal junction, extramammary Paget's disease, salivary duct, primary myelodysplastic syndrome, desmoplastic small round cell tumor, angiosarcoma, kidney malignant rhabdoid tumor, renal papillary carcinoma | 1 (1) |
Percentages are calculated based on all the “reporting” cases. See references 1-37 and 46-92 for case reports and series of PTTM.
n, number of cases.